Edition:
India

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.76USD
20 Sep 2019
Change (% chg)

-- (--)
Prev Close
$5.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
148,324
52-wk High
$6.04
52-wk Low
$2.40

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.22 December 23 Sep 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 3 3
(2) OUTPERFORM 3 3 3 3
(3) HOLD 1 1 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 5 6.80 8.30 5.40 4.05
Quarter Ending Dec-19 5 6.98 8.30 5.40 4.05
Year Ending Dec-19 5 28.76 33.40 24.70 22.57
Year Ending Dec-20 4 26.40 33.40 22.50 23.48
Earnings (per share)
Quarter Ending Sep-19 5 -0.22 -0.20 -0.25 -0.22
Quarter Ending Dec-19 5 -0.22 -0.19 -0.26 -0.21
Year Ending Dec-19 4 -0.89 -0.85 -0.98 -0.75
Year Ending Dec-20 4 -1.01 -0.58 -1.22 -0.88

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-19 8.20 5.33 2.87 34.98
Quarter Ending Mar-19 7.02 8.55 1.52 21.70
Quarter Ending Dec-18 7.29 4.91 2.38 32.59
Quarter Ending Sep-18 7.41 8.35 0.94 12.68
Quarter Ending Jun-18 12.71 11.69 1.02 8.01

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 6.80 6.81 6.66 8.21 4.05
Quarter Ending Dec-19 6.98 6.98 6.78 8.31 4.05
Year Ending Dec-19 28.76 28.76 28.05 33.27 22.57
Year Ending Dec-20 26.40 26.41 26.41 29.24 23.48

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 1 0 1
Quarter Ending Dec-19 0 1 0 1
Year Ending Dec-19 0 1 0 1
Year Ending Dec-20 0 1 0 1
Earnings